Arcutis Biotherapeutics, Inc. (ARQT) vs Legend Biotech Corporation Sponsored ADR (LEGN)
- Arcutis Biotherapeutics, Inc. ARQT 28.82 −0.96%
- Legend Biotech Corporation Sponsored ADR LEGN 18.48 −6.67%
Arcutis Biotherapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Arcutis Biotherapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are of similar size ($3.8B and $3.7B). Legend Biotech Corporation Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 131×. Arcutis Biotherapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 59.6%. Arcutis Biotherapeutics, Inc. has the higher net margin (6.15% vs −7.20%) and the higher return on invested capital (23.6% vs −9.54%). Across the 17 metrics below, Arcutis Biotherapeutics, Inc. leads on 11 and Legend Biotech Corporation Sponsored ADR on 6.
Valuation
Profitability
| Metric | ARQT | LEGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.14% | 56.58% | 65.16% |
| Operating margin | 7.38% | (5.06%) | 0.00% |
| Net margin | 6.15% | (7.20%) | 0.00% |
| Free cash flow margin | 8.42% | (9.58%) | 0.00% |
| Return on equity | 15.86% | (8.08%) | (56.36%) |
| Return on assets | 6.78% | (5.32%) | (48.04%) |
| Return on invested capital | 23.62% | (9.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack